Now showing items 1-1 of 1
A case with ataxia, optic neuropathy and polyneuropathy: is there any association with imatinib or natural course of chronic myeloid leukemia?
(Maltepe Tıp Dergisi, 2018)
Imatinib is a tyrosine kinase inhibitor as a antineoplastic agent which is indicated in chronic myeloid leukemia (CML), various hematologic and nonhematologic malignancies. Forty-seven years old male, with CML diagnosis ...